Their another work in investigating the prognostic role of IL-6 among patients with advanced cutaneous squamous cell carcinoma found both high serum levels of IL-6 at baseline and increase after PD-1 blockade immunotherapy predict unfavorable prognosis [22]. The gene discussed is IL6; the disease is cutaneous squamous cell carcinoma.